Dr Stephen McAdoo holds an Imperial College Clinician Researcher Fellowship, and is an Honorary Consultant Nephrologist at Imperial College Healthcare NHS Trust. His clinical and research interests are in autoimmune kidney diseases, with a particular focus on crescentic glomerulonephritis and systemic vasculitis.
et al., 2020, Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model, Kidney International, Vol:97, ISSN:0085-2538, Pages:1196-1207
et al., 2020, Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines, Rheumatology, Vol:59, ISSN:1462-0324, Pages:e24-e32
et al., 2019, Acute iron deprivation reprograms human macrophage metabolism and reduces inflammation in vivo, Cell Reports, Vol:28, ISSN:2211-1247, Pages:498-511.e5
et al., 2019, A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis, Rheumatology, Vol:58, ISSN:1462-0324, Pages:260-268
et al., 2019, Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis, Nephrology Dialysis Transplantation, Vol:34, ISSN:0931-0509, Pages:63-73
McAdoo SP, Pusey CD, 2017, Anti-glomerular basement membrane disease, Clinical Journal of the American Society of Nephrology, Vol:12, ISSN:1555-905X, Pages:1162-1172